Cargando…

New ways of assessing ovarian cancer response: metabolic imaging and beyond

In patients with advanced ovarian cancer, it can be challenging to evaluate response to neoadjuvant chemotherapy on computed tomography (CT) due to disseminated small volume disease and serosal disease. In addition, measuring the change in size of tumour burden takes time in order to allow tumour sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockall, Andrea, Munari, Alice, Avril, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460555/
https://www.ncbi.nlm.nih.gov/pubmed/23022953
http://dx.doi.org/10.1102/1470-7330.2012.9004
_version_ 1782244952118394880
author Rockall, Andrea
Munari, Alice
Avril, Norbert
author_facet Rockall, Andrea
Munari, Alice
Avril, Norbert
author_sort Rockall, Andrea
collection PubMed
description In patients with advanced ovarian cancer, it can be challenging to evaluate response to neoadjuvant chemotherapy on computed tomography (CT) due to disseminated small volume disease and serosal disease. In addition, measuring the change in size of tumour burden takes time in order to allow tumour shrinkage. Despite these challenges, serum CA-125 levels and CT are the standard tools for the assessment of treatment response in ovarian cancer. New functional imaging techniques may allow the identification of response earlier and with higher accuracy. In this review article, we describe the current literature on functional imaging techniques in ovarian cancer response assessment, focusing on fluorodeoxyglucose-positron emission tomography.
format Online
Article
Text
id pubmed-3460555
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-34605552014-06-13 New ways of assessing ovarian cancer response: metabolic imaging and beyond Rockall, Andrea Munari, Alice Avril, Norbert Cancer Imaging Advanced Ovarian Cancer In patients with advanced ovarian cancer, it can be challenging to evaluate response to neoadjuvant chemotherapy on computed tomography (CT) due to disseminated small volume disease and serosal disease. In addition, measuring the change in size of tumour burden takes time in order to allow tumour shrinkage. Despite these challenges, serum CA-125 levels and CT are the standard tools for the assessment of treatment response in ovarian cancer. New functional imaging techniques may allow the identification of response earlier and with higher accuracy. In this review article, we describe the current literature on functional imaging techniques in ovarian cancer response assessment, focusing on fluorodeoxyglucose-positron emission tomography. e-Med 2012-09-28 /pmc/articles/PMC3460555/ /pubmed/23022953 http://dx.doi.org/10.1102/1470-7330.2012.9004 Text en © 2012 International Cancer Imaging Society
spellingShingle Advanced Ovarian Cancer
Rockall, Andrea
Munari, Alice
Avril, Norbert
New ways of assessing ovarian cancer response: metabolic imaging and beyond
title New ways of assessing ovarian cancer response: metabolic imaging and beyond
title_full New ways of assessing ovarian cancer response: metabolic imaging and beyond
title_fullStr New ways of assessing ovarian cancer response: metabolic imaging and beyond
title_full_unstemmed New ways of assessing ovarian cancer response: metabolic imaging and beyond
title_short New ways of assessing ovarian cancer response: metabolic imaging and beyond
title_sort new ways of assessing ovarian cancer response: metabolic imaging and beyond
topic Advanced Ovarian Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460555/
https://www.ncbi.nlm.nih.gov/pubmed/23022953
http://dx.doi.org/10.1102/1470-7330.2012.9004
work_keys_str_mv AT rockallandrea newwaysofassessingovariancancerresponsemetabolicimagingandbeyond
AT munarialice newwaysofassessingovariancancerresponsemetabolicimagingandbeyond
AT avrilnorbert newwaysofassessingovariancancerresponsemetabolicimagingandbeyond